DCPN
CHANGE OF OWNER RECEIVED FROM IB
18/11/2025
Voltar para busca
Dado oficial do USPTO
GREENDROITIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
GREENDROITIN
ST13
US500000079303626Classe
1, 5, 35
Pedido
79303626
Registro
6674478
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
20/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 35
Data de depósito
29/10/2020
Data de registro
22/03/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/03/2022
Última transação
20/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
CN
Examinador
AGREDA,SAMANTHA LEIGH
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Hangzhou Skyherb Technologies Co. Ltd.
VIVATIS PHARMA GmbH
VIVATIS PHARMA ITALIA S.R.L.
Representantes
Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals and chemical substances derived from botanical extractsindustrial chemicals derived from botanical extracts or vegetal extracts or fungal extracts; botanical extractsvegetal extracts and fungal extracts for use in the manufacture of pharmaceuticalsnutritional supplementssanitary preparationsdietary supplementsdietetic preparations and substancesnutraceuticals and cosmetics; chemical and organic compositions and substancesindustrial chemicalsall for the manufacture of pharmaceuticalssanitary preparationsdietary supplementsdietetic preparations and substancesnutraceuticals; plant extracts for industrial purposesplant extractsvegetal extracts and fungal extracts for use in the manufacture of pharmaceuticalsnutritional supplementssanitary preparationsdietary supplementsdietetic preparations and substancesnutraceuticals and cosmetics; plant extracts for the food industryplant extractsvegetal extracts and fungal extracts for the manufacture of foods; botanical extractsbotanical extractsvegetal extracts and fungal extracts for use in the manufacture of cosmetics; plant extracts for use in the manufacture of pharmaceuticals; proteins for use in industrybeing protein for industrial use; food protein as a raw materialproteins for the food industry; proteins for use in the manufacture of food supplements; all of the foregoing containing chondroitin or chondroitin sulfate or salts thereof
Classe 5
Chondroitin-based preparations; pharmaceutical products for the treatment of psoriasisof stomach acid disorders and diseasesof gastro-oesophageal reflux diseaseof reflux esophagitisof urinary tract disorders and diseasesof rheumatismsof joint disorders and diseasesof disorders caused by arthrosis or osteoarthritisof osteoarticular inflammation and painfor improving joint function; botanical extracts being plant extractsfungal extracts for pharmaceutical purposes; food supplementsdietetic preparations adapted for medical use and dietetic food adapted for medical usenutraceuticals for use as dietary supplements; sanitary preparations for medical purposes; food supplements consisting of fungal extracts; plant extracts for pharmaceutical purposes; plant extracts being vegetal extracts for pharmaceutical purposes; protein dietary supplements; all of the foregoing containing chondroitin or chondroitin sulfate or salts thereof
Classe 35
Wholesale store and retail store servicesincluding via mail ordercommunication media and the internetall in the field of chemicals and chemical substances including chemicals and chemical substances derived from botanical extractschemical and organic compositions and substances for the manufacture of pharmaceuticalsall of the foregoing containing chondroitin or chondroitin sulfate or salts thereof; Wholesale store and retail store servicesincluding via mail ordercommunication media and the internetall in the field of sanitary preparationsdietary supplementsdietetic preparations and substancesnutraceuticalsplant extracts for industrial purposesplant extracts for the food industrybotanical extracts for use in the manufacture of cosmeticsplant extracts for use in the manufacture of pharmaceuticalsall of the foregoing containing chondroitin or chondroitin sulfate or salts thereof; Wholesale store and retail store servicesincluding via mail ordercommunication media and the internetall in the field of proteins for use in manufacturefood proteins used as raw materialsproteins for use in the manufacture of food supplementschondroitin-based preparationsall of the foregoing containing chondroitin or chondroitin sulfate or salts thereof; Wholesale store and retail store servicesincluding via mail ordercommunication media and the internetall in the field of pharmaceutical productsbotanical extracts for pharmaceutical purposesfood supplementsdietetic preparations and substancesnutraceuticalssanitary productsfood supplements consisting of fungal extractsplant extracts for pharmaceutical purposesvegetal extracts for pharmaceutical purposesprotein dietary supplementsall of the foregoing containing chondroitin or chondroitin sulfate or salts thereof; business management services relating to franchising
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/10/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/10/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/10/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/12/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
16/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/02/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/02/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/02/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/08/2022
FIMP
FINAL DISPOSITION PROCESSED
11/08/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
22/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2022
PUBO
PUBLISHED FOR OPPOSITION
04/01/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/12/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/12/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/12/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/12/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/10/2021
RFNT
REFUSAL PROCESSED BY IB
03/05/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/04/2021
RFRR
REFUSAL PROCESSED BY MPU
15/04/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/04/2021
CNRT
NON-FINAL ACTION WRITTEN
09/04/2021
DOCK
ASSIGNED TO EXAMINER
31/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
13/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/02/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GREENDROITIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.